Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 15, 2024

Total Value: $1.11B (100.0% shares, 0.0% debt)

Holdings (34)

INSM INSMED INC 15.4%
Value $171M Shares 5,511,721 Share Price $30.99 * Est. Cost/Share $17.79 Unrealized @ Report Date +45.8%
FOLD AMICUS THERAPEUTICS INC 13.3%
Value $147M Shares 10,373,715 Share Price $14.19 * Est. Cost/Share $9.63 Unrealized @ Report Date +18.0%
BMRN BIOMARIN PHARMACEUTICAL INC 13.0%
Value $145M Shares 1,500,749 Share Price $96.42 * Est. Cost/Share $83.16 Unrealized @ Report Date +6.4%
BIIB BIOGEN INC 8.9%
Value $98.44M Shares 380,417 Share Price $258.77 * Est. Cost/Share $264.98 Unrealized @ Report Date -7.3%
UTHR UNITED THERAPEUTICS CORP 7.8%
Value $87.03M Shares 395,784 Share Price $219.89 * Est. Cost/Share $89.23 Unrealized @ Report Date +158.3%
ACAD ACADIA PHARMACEUTICALS INC 6.8%
Value $75.44M Shares 2,409,556 Share Price $31.31 * Est. Cost/Share $28.41 Unrealized @ Report Date -15.9%
PRTA PROTHENA CORP PLC 5.4%
Value $60.33M Shares 1,660,057 Share Price $36.34 * Est. Cost/Share $21.46 Unrealized @ Report Date +79.4%
— REVANCE THERAPEUTICS INC 4.1%
Value $46.04M Shares 5,237,284 Share Price $8.79 Est. Cost/Share $21.40 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 3.9%
Value $42.97M Shares 1,376,950 Share Price $31.21 * Est. Cost/Share $24.23 Unrealized @ Report Date +48.3%
ALNY ALNYLAM PHARMACEUTICALS INC 2.7%
Value $29.56M Shares 154,437 Share Price $191.41 * Est. Cost/Share $170.34 Unrealized @ Report Date 0.0%
EHTH EHEALTH INC 2.2%
Value $23.89M Shares 2,739,379 Share Price $8.72 * Est. Cost/Share $38.13 Unrealized @ Report Date -78.6%
— SAGE THERAPEUTICS INC 1.9%
Value $21.49M Shares 991,525 Share Price $21.67 Est. Cost/Share $42.84 Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 1.7%
Value $19.37M Shares 200,905 Share Price $96.43 Est. Cost/Share $111.32 Unrealized @ Report Date -13.8%
IOVA IOVANCE BIOTHERAPEUTICS INC 1.5%
Value $17.13M Shares 2,106,792 Share Price $8.13 * Est. Cost/Share $5.23 Unrealized @ Report Date 0.0%
ALKS ALKERMES PLC 1.5%
Value $16.74M Shares 603,400 Share Price $27.74 * Est. Cost/Share $22.36 Unrealized @ Report Date +16.2%
— NEVRO CORP 1.5%
Value $16.15M Shares 750,371 Share Price $21.52 Est. Cost/Share $21.87 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 1.4%
Value $15.26M Shares 55,705 Share Price $274.00 * Est. Cost/Share $149.18 Unrealized @ Report Date +58.9%
ANAB ANAPTYSBIO INC 1.3%
Value $14.71M Shares 686,882 Share Price $21.42 * Est. Cost/Share $18.38 Unrealized @ Report Date -6.2%
SNDX SYNDAX PHARMACEUTICALS INC 0.9%
Value $10.21M Shares 472,600 Share Price $21.61 * Est. Cost/Share $16.84 Unrealized @ Report Date -8.7%
CYTK CYTOKINETICS INC 0.8%
Value $9.327M Shares 111,717 Share Price $83.49 * Est. Cost/Share $6.71 Unrealized @ Report Date +439.4%
NVCR NOVOCURE LTD 0.8%
Value $8.389M Shares 561,908 Share Price $14.93 * Est. Cost/Share $58.84 Unrealized @ Report Date -77.3%
— VERVE THERAPEUTICS INC 0.7%
Value $8.027M Shares 575,817 Share Price $13.94 Est. Cost/Share $13.94 Unrealized @ Report Date —
GOSS GOSSAMER BIO INC 0.6%
Value $6.53M Shares 5,958,888 Share Price $1.10 * Est. Cost/Share $1.61 Unrealized @ Report Date -54.2%
— BLUEBIRD BIO INC 0.4%
Value $4.6M Shares 3,333,333 Share Price $1.38 Est. Cost/Share $1.38 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.4%
Value $4.413M Shares 5,102,193 Share Price $0.87 Est. Cost/Share $16.36 Unrealized @ Report Date —
RLMD RELMADA THERAPEUTICS INC 0.3%
Value $3.032M Shares 732,400 Share Price $4.14 * Est. Cost/Share $3.27 Unrealized @ Report Date -9.5%
MIRM MIRUM PHARMACEUTICALS INC 0.2%
Value $1.91M Shares 64,700 Share Price $29.52 * Est. Cost/Share $15.56 Unrealized @ Report Date +94.5%
VNDA VANDA PHARMACEUTICALS INC 0.1%
Value $1.177M Shares 278,985 Share Price $4.22 * Est. Cost/Share $11.21 Unrealized @ Report Date -64.0%
VYNE VYNE THERAPEUTICS INC PIPE 0.1%
Value $1.038M Shares 445,434 Share Price $2.33 * Est. Cost/Share $3.12 Unrealized @ Report Date 0.0%
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value $995K Shares 110,719 Share Price $8.99 * Est. Cost/Share $23.56 Unrealized @ Report Date -69.1%
TSHA TAYSHA GENE THERAPIES INC 0.1%
Value $938K Shares 529,861 Share Price $1.77 * Est. Cost/Share $1.99 Unrealized @ Report Date 0.0%
SGHT SIGHT SCIENCES INC 0.1%
Value $897K Shares 173,790 Share Price $5.16 * Est. Cost/Share $3.09 Unrealized @ Report Date 0.0%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $791K Shares 225,465 Share Price $3.51 * Est. Cost/Share $5.95 Unrealized @ Report Date -48.1%
URGN UROGEN PHARMA LTD 0.0%
Value $368K Shares 24,500 Share Price $15.00 * Est. Cost/Share $27.01 Unrealized @ Report Date -51.9%